Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple-Combination Cream Plus Microneedling With TXA vs PRP for Melasma
NCT07893067Phase 4Active, not recruiting
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid, autologous platelet rich gel in melasma, sponsored by Bangabandhu Sheikh Mujib Medical University. Started Oct 2026; status: active, not recruiting.
02
Drugs
tranexamic acidautologous platelet rich gel
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07893067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07893067.